Despite notable scientific and medical advances, broader political, socioeconomic and behavioural factors continue to undercut the response to the COVID-19 pandemic1,2. Here we convened, as part of this Delphi study, a diverse, multidisciplinary panel of 386 academic, health, non-governmental organization, government and other experts in COVID-19 response from 112 countries and territories to recommend specific actions to end this persistent global threat to public health. The panel developed a set of 41 consensus statements and 57 recommendations to governments, health systems, industry and other key stakeholders across six domains: communication; health systems; vaccination; prevention; treatment and care; and inequities. In the wake of nearly three years of fragmented global and national responses, it is instructive to note that three of the highest-ranked recommendations call for the adoption of whole-of-society and whole-of-government approaches1, while maintaining proven prevention measures using a vaccines-plus approach2 that employs a range of public health and financial support measures to complement vaccination. Other recommendations with at least 99% combined agreement advise governments and other stakeholders to improve communication, rebuild public trust and engage communities3 in the management of pandemic responses. The findings of the study, which have been further endorsed by 184 organizations globally, include points of unanimous agreement, as well as six recommendations with >5% disagreement, that provide health and social policy actions to address inadequacies in the pandemic response and help to bring this public health threat to an end.
Healthcare workers were prioritized in vaccination campaigns globally because they are exposed to the highest risk of contamination by SARS-CoV-2. This study evaluated the self-reported post-vaccination side effects of inactivated (BBIBP-CorV and CoronaVac) and adenoviral vector-based (AZD1222, Gam-COVID-Vac and Ad26.COV2.S) vaccines among Algerian healthcare workers using a validated questionnaire. The final analysis included 721 healthcare workers, with a predominance of females (59.1%) and younger individuals 20–30 years old (39.4%). Less than half (49.1%) of the respondents reported at least one local side effect, while 53.8% reported at least one systemic side effect. These side effects were more prevalent among viral vector vaccinees than inactivated virus vaccinees. The most common local side effects were injection site pain (39%) and arm pain (25.4%), while fatigue (34.4%), fever (28.4%), headache (24.8%) and myalgia (22.7%) were the most prevalent systemic side effects. The side effects appeared earlier among inactivated virus vaccines recipients and generally lasted for 2 to 3 days for the two vaccinated groups. The risk factors associated with a higher prevalence of side effects included female gender, allergic individuals, individuals with regular medication, those who contracted the COVID-19 disease and those who received two doses for both inactivated and viral-based vaccines groups. Despite the higher prevalence of post-vaccination side effects among adenoviral vector vaccines recipients, both vaccines groups were equally effective in preventing symptomatic infections, and no life-threatening side effects were reported in either vaccine group.
Background The coronavirus disease 2019 (COVID-19) is reported in Algeria on February 25th, 2020. Since then, the number is still increasing leading to a total number of 36,699 cases and 1333 deaths on August 12th, 2020. Thus, comprehension of the epidemic curve is very important to predict its evolution and subsequently adapt the best prevention strategies. In this way, the current study was conducted to estimate the parameters of the classical SIR model and to predict the peak of the COVID-19 epidemic in Algeria using data from February 25th, 2020 to August 12th, 2020. Results Results showed that the peak of the epidemic will be reached on September 8th, 2021 and the total infected persons will exceed 800,000 cases at the end of the epidemic. Also, more than 15 million persons will be susceptible. The reproduction number (R0) is estimated at 1.23254. Conclusion These results may be helpful for the Algerian authorities to adapt their strategies and may be taken into consideration in the future phase of discontainment.
Covid-19 is an infectious disease caused by a new virus called SARS-CoV-2. First reported in Wuhan, in China, the disease is now considered as a pandemic of global interest. Algeria is the fourth most affect countries in Africa with 2718 positive cases in April 20 and the 55th in the world. Since its apparition the Algerian government has implemented a range of measures to reduce the spread of the virus. The chronology of actions taken is reported in this manuscript.
The world is facing to a new pandemic called coronavirus disease 2019 (COVID-19). In the absence of an efficient treatment or vaccines, Governments have adopted different preventive measures to limit the spread of this disease such as social distancing, mask wearing and quarantine. However, the response of people to these measures was one of the most obstacle in their application demonstrating a missing link in the concept of health education. The current manuscript describe the importance of school health education and the necessity of investing in this concept as a lesson from the COVID-19 pandemic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.